Selvita and Merck announce drug discovery cooperation

WSE-listed Polish biotechnological firm Selvita and German pharmaceutical company Merkc have signed a three-year contract aimed at validating new therapeutic concepts in the field of oncology, a press release read. The deal is valued at PLN 18.8 million. The aim of the collaboration is to deliver potential first-in-class small molecules as lead candidate drugs for…

This content is for Silver 6 months, Gold 1 Year and Bronze 2 weeks members only.
Log In Buy Subscription
Pin It